YAP knockdown repressed autophagy in fibroblasts to accelerate wound healing through regulating En1/mTOR axis

C-J Chen1, K Kishi

  • 1Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo, Japan. kkishi@a7.keio.jp.

Abstract

Insights

Yes-associated protein (YAP) knockdown accelerates wound healing by reducing fibroblast autophagy via the Engrailed-1/mammalian target of rapamycin pathway. This finding offers new insights into wound repair mechanisms.

Area of Science:

  • Cell Biology
  • Wound Healing Research
  • Molecular Mechanisms

Background:

  • Wound repair dysfunction is a significant global health concern.
  • Yes-associated protein (YAP) is implicated in wound healing, but its role in regulating autophagy requires further investigation.

Purpose of the Study:

  • To investigate how YAP influences wound healing by modulating autophagy.
  • To elucidate the molecular pathways involved in YAP-mediated wound repair.

Main Methods:

  • An in vivo mouse model of excisional wounds was established.
  • Experiments involved the use of an autophagy inhibitor (3-MA) and YAP knockdown via siRNA electrotransfection.
  • Fibroblast proliferation, migration, and autophagy levels were assessed.

Main Results:

  • Autophagy inhibition (3-MA) accelerated wound closure in vivo.
  • YAP knockdown enhanced fibroblast proliferation and migration while reducing autophagy, leading to faster wound healing.
  • YAP positively regulates Engrailed-1 (En1) expression; En1 knockdown mimicked YAP knockdown effects on fibroblasts and autophagy via the mTOR pathway.

Conclusions:

  • YAP knockdown accelerates wound closure by repressing autophagy in fibroblasts.
  • The En1/mTOR axis is a key mediator in YAP's regulation of fibroblast autophagy and wound healing.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K